NuVasive bolsters spinal portfolio with 2 FDA clearances, 1 product launch

Spinal Tech
Alan Condon -

NuVasive on May 5 expanded its advanced materials science implant portfolio with two FDA 510(k) clearances and one device launch.

Three things to know:

1. The FDA provided clearance for the company's Modulus ALIF, a porous titanium implant, and Cohere TLIF-O, a porous PEEK implant.

2. NuVasive launched the Modulus XLIF dual sided plate, which is a low-profile, anti-migration plate that allows for two points of fixation in extreme lateral interbody fusion surgeries.

3. NuVasive's AMS implant portfolio features devices designed to improve the osseointegration and biomechanical properties of materials used in spine surgeries.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.